Curi RMB Capital LLC Has $2.32 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Curi RMB Capital LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,453 shares of the medical equipment provider’s stock after selling 384 shares during the quarter. Curi RMB Capital LLC’s holdings in Intuitive Surgical were worth $2,324,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP lifted its holdings in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the period. Onefund LLC lifted its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after acquiring an additional 18 shares during the period. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its position in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 in the last three months. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on ISRG. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial dropped their price target on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.81.

Intuitive Surgical Stock Performance

ISRG opened at $482.74 on Monday. The company’s 50-day simple moving average is $522.23 and its two-hundred day simple moving average is $532.71. The stock has a market capitalization of $171.94 billion, a P/E ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $364.31 and a 52-week high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.